Latest APGI News
Immune system editing offers a possible target for pancreatic cancer vaccine
Pancreatic cancer is one of the most aggressive cancers and five-year survival rates are just 10%. A very small number of patients live longer, with less than 2% surviving more than 10 years after diagnosis. Researchers have been working to understand how this cancer...
PanKind foundation supports new study to improve immunotherapy outcomes in pancreatic cancer
The Avner Australian Pancreatic Cancer Matrix Atlas group (APMA) will investigate a potential new way to improve immunotherapy outcomes for patients with pancreatic cancer using a class of drug that can reduce the metabolic rewiring of the cancer cells thanks to a...
World Pancreatic Cancer Awareness Month
November is recognised as World Pancreatic Cancer Awareness Month. We take time to raise awareness of the disease, celebrate survivors and acknowledge pancreatic cancer research. Pancreatic cancer has now become the third leading cause of cancer deaths...
Other News
Contact APGI
Australian Pancreatic Cancer Genome Initiative
The Kinghorn Cancer Centre
Garvan Institute of Medical Research
370 Victoria St, Darlinghurst
NSW 2010
Australia
On Twitter
